insulin like growth factor 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of transcription by RNA polymerase II |
|
|
| negative regulation of transcription by RNA polymerase II |
|
|
| ossification |
|
|
| osteoblast differentiation |
|
|
| in utero embryonic development |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| insulin receptor binding |
|
|
| insulin-like growth factor receptor binding |
|
|
| insulin-like growth factor receptor binding |
|
|
| insulin-like growth factor receptor binding |
|
|
| insulin-like growth factor receptor binding |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:14681 | Silver-Russell syndrome | |
| DOID:3594 | choriocarcinoma | |
| DOID:684 | hepatocellular carcinoma | |
| DOID:7148 | rheumatoid arthritis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026